Development of a Homogeneous Time-Resolved Fluorescence Assay for High Throughput Screening to Identify Lck Inhibitors: Comparison with Scintillation Proximity Assay and Streptavidin-Coated Plate Assay

Abstract

This study details the development of a homogeneous time-resolved fluorescence (HTRF) high throughput screening assay to identify inhibitors of Lck. HTRF was compared with scintillation proximity and streptavidin-coated plate assays. Because of the differences in the sensitivity of detection of phosphotyrosine among the three assays, different amounts of enzyme were used. However, the concentrations of the other assay components were standardized. When using similar assay conditions, the calculated IC₅₀ values of inhibitory compounds were independent of assay format. Furthermore, filtration experiments revealed that phosphorylation of a biotinyl poly-Glu,Ala, Tyr peptide substrate was less than autophosphorylation of the Lck enzyme; this was due to the low K_m value for biotinyl poly-Glu,Ala,Tyr. In the HTRF assay, small amounts of enzyme and high concentrations of ATP could be used, thereby minimizing the effects of autophosphorylation. Higher ATP concentration would also minimize the effect of ATP competitors. Using this technology, it may be possible to find novel kinase inhibitors that do not act at the ATP binding site of protein tyrosine kinases.

References

Yarden, Y. (1988). Growth factor receptor tyrosine kinases. Annu. Rev. Biochem. 57:443.

Hunter, T. (1997). Oncoprotein networks. Cell 88:333.

Boschelli, D.H. (1999). Small molecule inhibitors of receptor tyrosine kinases. Drugs of the Future 24:515.

Bhagwat, S.S. , Manning, A.M. , Hoekstra, M.F. , Lewis, A. (1999). Gene-regulating protein kinases as important anti-inflammatory targets. Drug Discov. Today 4:472.

Wingfield, J.M. (1998). Developing effective assay in HTS. Drug Discov. Today 3:97.

Bosworth, N. , Towers, P. (1989). Scintillation proximity assay. Nature 341:167.

Nakayama, G.R. , Nova, M.P. , Parandoosh, Z. (1998). A scintillating microplate assay for the assessment of protein kinase activity. J. Biomol. Screen. 3:43.

Hemmild, I. , Webb, S. (1997). Time-resolved fluorometry: An overview of the labels and core technologies for drug screening applications. Drug Discov. Today 2:373.

Kolb, J.M. , Yamanaka, G. , Manly, S.P. (1996). Use of a novel homogeneous fluorescent technology in high throughput screening. J. Biomol. Screen. 1:203.

10.

Liu, J. , Gallagher, M. , Horlick, R.A. , Robbins, A.K. , Webb, M.L. (1998). A time-resolved fluorometric assay for galanin receptors. J. Biomol. Screen. 3:199.

11.

Kolb, A.J. , Kaplita, P.V. , Hayes, D.J. , Park, Y-W. , Pernell, C. , Major, J.S. , Mathis, G. (1998). Tyrosine kinase assays adapted to homogeneous time-resolved fluorescence. Drug Discov. Today 3:333.

12.

Gaarde, W.A. , Hunter, T. , Brady, H. , Murray, B.W. , Goldman, M.E. (1997). Development of a nonradioactive, time-resolved fluorescence assay for the measurement of Jun N-terminal kinase activity. J. Biomol. Screen. 2:213.

13.

Marchildon, G.A. , Casnellie, J.E. , Walsh, K.A. , Krebs, E.G. (1984). Covalently bound myristate in a lymphoma tyrosine protein kinase. Proc. Natl. Acad. Sci. U. S. A. 81:7679.

14.

Perlmutter, R.M. , Marth, J.D. , Ziegler, S.F. , Garvin, A.M. , Pawar, S. , Cooke, M.P. , Abraham, K.M. (1988). Specialized protein tyrosine kinase proto-oncogenes in hematopoietic cells. Biochim. Biophys. Acta 948:245.

15.

Watts, J.D. , Wilson, G.M. , Ettehadieh, E. , Clark-Lewis, I. , Kubanek, C-A. , Astell, C.R. , Marth, J.D. , Aebersold, R. (1992). Purification and initial characterization of the lymphocyte-specific protein-tyrosyl kinase p56lck from a baculovirus expression system. J. Biol. Chem. 267:901.

16.

Ausubel, F.M. , Brent, R. , Kingston, R.F. , Moore, D.D. , Seidman, J.G. , Smith, J.A. , Struhl, K. eds. (1992). Short protocols in molecular biology. John Wiley and Sons, New York.

17.

Bayer, E.A. , Wilchek, M. (1990). Protein biotinylation. Methods Enzymol. 184:138-166.

18.

Flotow, H. , Purton, T.J. , Whitaker, D.P. , Williams, D.H. , Wilkinson, S.E. (1996). Substrate specificity and inhibitor profile of human recombinant p56lck from a bacurovirus expression vector. Inflamm. Res. 45:412.

19.

Kovalenko, M. , Rönnstrand, L. , Heldin, C-H. , Loubtchenkov, M. , Gazit, A. , Levitzki, A. , Böhmer, F.D. (1997). Phosphorylation site-specific inhibition of platelet-derived growth factor β-receptor autophosphorylation by the receptor blocking tyrophostin AG 1296. Biochemistry 36:6260.

20.

Kendall, R.L. , Rutledge, R.Z. , Mao, X. , Tebben, A.J. , Hungate, R.W. , Thomas, K.A. (1999). Vascular endothelial growth factor receptor KDR tyrosine kinase activity is increased by autophosphorylation of two activation loop tyrosine residues. J. Biol. Chem. 274:6453.

21.

Posner, I. , Engel, M. , Levitzki, A. (1992). Kinetic model of the epidermal growth factor (EGF) receptor tyrosine kinase and a possible mechanism of its activation by EGF. J. Biol. Chem. 267:20638.

22.

Wang, S. , Lehr, R. , Stevis, P. , Wang, X-M. , Trevillyan, J. , Faltymek, C.R. (1994). p56lck Interactions accelerate autophosphorylation and enhance activity toward exogenous substrates. Arch. Biochem. Biophys. 315:60.

23.

Cushman, M. , Nagarathnam, D. , Burg, D.L. , Geahlen, R.L. (1991). Synthesis and protein-tyrosine kinase inhibitory activities of flavonoid analogues. J. Med. Chem. 34:798.